Babar Khan, M., Ruggieri, R., Tran, N., Sarkaria, J., MacDiarmid, J., Brahmbhatt, H., . . . Symons, M. (2019). DDIS-18. NANOCELL-MEDIATED DELIVERY OF MIR-34A COUNTERACTS TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA. Neuro Oncol.
Citación estilo ChicagoBabar Khan, Muhammad, Rosamaria Ruggieri, Nhan Tran, Jann Sarkaria, Jennifer MacDiarmid, Himanshu Brahmbhatt, John Boockvar, y Marc Symons. "DDIS-18. NANOCELL-MEDIATED DELIVERY OF MIR-34A COUNTERACTS TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA." Neuro Oncol 2019.
Cita MLABabar Khan, Muhammad, et al. "DDIS-18. NANOCELL-MEDIATED DELIVERY OF MIR-34A COUNTERACTS TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA." Neuro Oncol 2019.
Precaución: Estas citas no son 100% exactas.